ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 87 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $8,876,000 | +19.5% | 963,700 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $7,430,000 | -34.6% | 963,700 | -3.0% | 0.00% | -33.3% |
| Q3 2016 | $11,360,000 | +214.0% | 993,900 | +238.2% | 0.01% | +200.0% |
| Q2 2016 | $3,618,000 | +21.8% | 293,900 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $2,971,000 | -55.2% | 293,900 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $6,625,000 | +42.9% | 293,900 | +5.2% | 0.00% | +50.0% |
| Q3 2015 | $4,635,000 | -17.4% | 279,400 | +12.1% | 0.00% | -33.3% |
| Q2 2015 | $5,609,000 | -12.7% | 249,300 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $6,427,000 | +18.5% | 249,300 | 0.0% | 0.00% | +50.0% |
| Q4 2014 | $5,425,000 | +15.0% | 249,300 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $4,719,000 | -21.5% | 249,300 | -3.3% | 0.00% | -33.3% |
| Q2 2014 | $6,009,000 | -24.6% | 257,900 | +8.9% | 0.00% | -25.0% |
| Q1 2014 | $7,968,000 | +14.0% | 236,800 | 0.0% | 0.00% | +33.3% |
| Q4 2013 | $6,990,000 | +108.8% | 236,800 | +8.3% | 0.00% | +50.0% |
| Q3 2013 | $3,347,000 | – | 218,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|